Treatment adherence redefined: A critical analysis of technotherapeutics

Nursing Inquiry

Volumn 20, Issue 1, 2013, Pages 60-70

  Gagnon, Marilou ^a   Jacob, Jean Daniel ^a   Guta, Adrian ^b  

^a UNIVERSITY OF OTTAWA   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Foucault; HIV; Power; Surveillance; Technology; Treatment adherence

Indexed keywords

CHRONIC DISEASE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV INFECTIONS; HUMAN; MEDICAL TECHNOLOGY; PATIENT COMPLIANCE; PHILOSOPHY; TELEMEDICINE;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BIOMEDICAL TECHNOLOGY; CHRONIC DISEASE; HIV INFECTIONS; HUMANS; PATIENT COMPLIANCE; PHILOSOPHY, NURSING; TELEMEDICINE;

EID: 84865013789     PISSN: 13207881     EISSN: 14401800     Source Type: Journal    
DOI: 10.1111/j.1440-1800.2012.00595.x     Document Type: Article

References (54)

1. Armstrong H, P Armstrong and D Coburn. 2001. Unhealthy times: Political economy perspectives on health and care in Canada. Don Mills, ON: Oxford University Press.
2. Bashford A. 2006. Global biopolitics and the history of world health. History of the human sciences 19: 67-88.
3. Beni JB. 2011. Technology and the healthcare system: Implications for patient adherence. International Journal of Electronic Healthcare 6: 117-137.
4. Brown T and M Bell. 2008. Imperial or postcolonial governance? Dissecting the genealogy of a global public health strategy Social Science & Medicine 67: 1571-1579.
5. Brown T and DLB Watson. (2009). Governing un/healthy populations. In A companion to health and medical geography, eds T Brown, S McLafferty and G Moon, 477-493. Oxford, UK: Wiley-Blackwell.
6. Bryan B. 2009. "Hail the cure!": Althusser, biotechnology, and biopolitics. In Critical interventions in the ethics of healthcare: Challenging the principle of autonomy in bioethics, eds SJ Murray and D Holmes, 81-96. Burlington, VT: Ashgate Publishing Company.
7. Check Hayden E. 2010. 'Seek, test and treat' slows HIV. Nature 463: 1006.
8. Clarke AE, JK Shim, L Mamo, JR Fosket and JR Fishman. 2003. Biomedicalization: Technoscientific transformations of health, illness, and U.S. biomedicine. American Sociological Review 68: 161-194.
9. Coburn D. 2000. Income inequality, social cohesion and the health status of populations: The role of neo-liberalism. Social Science & Medicine 51: 135-146.
10. Conway B and H Tossonian. 2011. Comprehensive approaches to the diagnosis and treatment of HIV infection in the community: Can "Seek and Treat" really deliver? Current Infectious Disease Report 13: 68-74.
11. nd edn. Los Angeles, CA: Sage Publications.
12. Dreyfus HL and P Rabinow. 1982. Michel Foucault: Beyond structuralism and hermeneutics. Chicago, IL: University of Chicago Press.
13. Duran S, M Saves, B Spire, V Cailleton, A Sobel, P Carrieri, D Salmon, JP Moatti, C Leport and APRICO Study Group. 2001. Failure to maintain long-term adherence to highly active antiretroviral therapy: The role of lipodystrophy. AIDS 15: 2441-2444.
14. Ellin N. 1997. Architecture of fear. New York, NY: Princeton Architectural Press.
15. Foucault M. 1980. Power/knowledge: Selected interviews and other writings. Toronto, ON: Random House of Canada.
16. Foucault M. 1984. On the genealogy of ethics: An overview of work in progress. In The Foucault reader, ed P Rabinow, 340-372. New York, NY: Patheon Books.
17. Foucault M. 1990. The history of sexuality (volume 1: An introduction). New York, NY: Vintage Books.
18. Foucault M. 1995. Discipline & punish. The birth of the prison. New York, NY: Vintage Books.
19. Foucault M. 2003a. Govermentality. In The essential Foucault: Selections from essential works of Foucault 1954-1984, eds P Rabinow and N Rose, 229-245. New York, NY: The New Press.
20. Foucault M. 2003b. "Society must be defended": Lectures at the college De France 1975-1976. New York, NY: Picador.
21. Gordon C. (1991). Governmental rationality: An introduction. In The Foucault effect: studies in governmentality, eds G Burchell, C Gordon and P Miller, 1-51. Chicago, IL: University of Chicago Press.
22. Granich RM, CF Gilks, C Dye, KM De Cock and BG Williams. 2009. Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: A mathematical model. The Lancet 373: 48-57.
23. Granich R, S Crowley, M Vitoria, C Smyth, JG Kahn, R Bennett, YR Lo, Y Southeyrand and B Williams. 2010. Highly active antiretroviral treatment as prevention of HIV transmission: Review of scientific evidence and update. Current Opinion in HIV and AIDS 5: 298-304.
24. Hamann TH. 2009. Neoliberalism, governmentality, and ethics. Foucault Studies 6: 37-59.
25. Hardon AP, D Akurut, C Comoro, C Ekezie, HF Irunde, T Gerrits, J Kglatwana et al. 2007. Hunger, waiting time and transport costs: Time to confront challenges to ART adherence in Africa. AIDS Care 19: 658-665.
26. Harvey D. 2005. A brief history of neoliberalism. Oxford: Oxford University Press.
27. Haynes RB, E Ackloo, N Sahota, HP McDonald and X Yao. 2008. Interventions for enhancing medication adherence. Cochrane Database of Systematic Reviews 2: 1-127.
28. Holmes D. 2001. From iron gaze to nursing care: Mental health nursing in the era of panopticism. Journal of Psychiatric and Mental Health Nursing 8: 7-15.
29. Hoover A and K Howell. 2010. Rx for health: Engineers design pill that signals it has been swallowed. University of Florida News. http://news.ufl.edu/2010/03/31/antenna-pill-2/ (accessed 1 May 2011).
30. Johnston KM, AR Levy, VD Lima, RS Hogg, MW Tyndall, P Gustafson, A Briggs and JSG Montaner. 2010. Expanding access to HAART: A cost-effective approach for treating and preventing HIV. AIDS 24: 1929-1935.
31. Lemke T. 2011. Biopolitics: An advanced introduction. New York, NY: New York University Press.
32. Lima VD, RS Hogg, PR Harrigan, E Wood, B Yip and JSG Montaner. 2007. The impact of HAART on HIV transmission: The interplay of HIV-1 RNA plasma viral load, adherence and drug resistance over time. Poster Presentation WEPEC011. International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention.
33. Lupton D. 1999. Risk. London: Routledge.
34. McArthur JC, BJ Brew and A Nath. 2005. Neurological complications of HIV infection. Lancet Neurology 4: 543-555.
35. Mehta S, RD Moore and NM Graham. 1997. Potential factors affecting adherence with HIV therapy. AIDS 11: 1665-1670.
36. Michael MG and K Michael. 2010. Toward a state of überveillance. IEEE Technology and Society Magazine 22: 9-16.
37. Mill E, JB Nachega, DR Bangsberg, S Singh, B Rachlis, P Wu, K Wilson, I Buchan, CJ Gill and C Cooper. 2006. Adherence to HAART: A systematic review of developed and developing nation patient-reported barriers and facilitators. PLOS Medicine 3: e438.
38. Murray SJ. 2009. The perils of scientific obedience: Bioethics under the spectre of biofascism. In Critical interventions in the ethics of healthcare, eds SJ Murray and D Holmes, 97-113. London: Ashgate Publishing Company.
39. Navarro V. 2007. Neoliberalism, globalization, and inequalities: Consequences for health and quality of life. Amityville, NY: Baywood Publisher.
40. Ostenberg L and T Blaschke. 2005. Adherence to medication. The New England Journal of Medicine 353: 487-497.
41. Paterson D, S Swindells, J Mohr, M Brester, EN Vergis, C Squier, M Wagner and N Singh. 2000. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Annals of Internal Medicine 133: 21-30.
42. Patton C. 2011. Rights language and HIV treatment: Universal care or population control? Rhetoric Society Quarterly 41: 250-266.
43. Petersen A. 1997. Risk, governance and the new public health. In Foucault: Health and medicine, eds A Peterson and R Bunton, 189-206. London: Routledge.
44. Rifkin J. 1998. The biotech century: Harnessing the gene and remaking the world. New York, NY: Jeremy P. Tarcher/Putnam.
45. Rintamaki LS, TC Davis, S Skripkauskas, CL Bennett and MS Wolf. 2006. Social stigma concerns and HIV medication adherence. AIDS Patient Care STDs 20: 359-368.
46. Robertson A. 2001. Biotechnology, political rationality and discourses on health risk. Health 5: 293-309.
47. Rose N. 1996. Governing "advanced" liberal democraties. In Foucault and political reason: Liberalism, neo-liberalism and rationalities of government, eds A Barry, T Osborne and N Rose, 37-64. London: The University of Chicago Press.
48. Rose N. 2007. The politics of life itself: Biomedicine, power, and subjectivity in the twenty-first century. Princeton, NJ: Princeton University Press.
49. Schambelan M, CA Benson, A Carr, JS Currier, MP Dube, JG Gerber, SK Grinspoon et al. 2002. Management of metabolic complications associated with antiretroviral therapy for HIV-1 infection: Recommendations of an International AIDS Society-USA panel. Journal of Acquired Immune Deficiencies Syndrome 31: 257-275.
50. Sonneville R, H Ferrand, F Tubach, C Roy, L Bouadma, IF Klein, A Foucrier, B Regnier, B Mourvillier and M Wolff. 2011. Neurological complications of HIV infection in critically ill patients: Clinical features and outcomes. The Journal of Infection 62: 301-308.
51. Straub S. 2011. Where is treatment as prevention heading: Treatment refusal = criminal behaviour? http://positivelite.com/content/news/legal/item/where-is-treatment-as-prevention-heading-treatment-refusal-criminal-behaviour (accessed 31 December 2011).
52. Taege A. 2011. Seek and treat: HIV update 2011. Cleveland Clinical Journal of Medicine 78: 95-100.
53. World Health Organization. 2003. Adherence to long-term therapies: Evidence for action. Geneva, Switzerland: World Health Organization.
54. Yar M. 2003. Panoptic power and the pathologisation of vision: Critical reflections on the Foucauldian thesis. Surveillance and Society 1: 254-271.